1. Glickman FS. Lepra, psora, psoriasis. J Am Acad Dermatol. 1986;14(5 Pt 1):863–6.
2. Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, et al. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol. 2007;143:239–42.
3. WHO. Global report on psoriasis. 2016.
http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf
. Accessed 27 Nov 2016.
4. Ortonne JP, Prinz JC. Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis. Eur J Dermatol. 2004;14(1):41–5.
5. Kubanova AA, Kubanov AA, Melechina LE, Bogdanova EB. Organization of medical care on the profile of “dermatovenereology” in the Russian Federation. The dynamics of the incidence of infections, sexually transmitted diseases, skin diseases and subcutaneous tissue, 2013–2015. Vestn Dermatol Venerol. 2016;3:12–28.